In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

445 News Items found
In the Lab
Image of two sets of embryonic cells
The Dual Life of PTEN: Gene Mutations Contribute to Both Cancer and Birth Defects

MSK investigators have shown that a gene mutation linked to many kinds of cancer can also cause birth defects of the nervous system.
Feature
Vincent Laudone, Chief of Surgery at the Josie Robertson Surgery Center
The Art of Listening: Using Patient Feedback to Improve Cancer Care

Why asking our patients how they’re doing, and listening to what they have to say, teaches us how to care for them.
In the Lab
Physician-scientist Omar Abdel-Wahab
Research Suggests How Boosting Neoantigens Can Make Immunotherapy More Effective

In mice, drugs that change the way proteins are assembled appear to make checkpoint inhibitor drugs work better.
Finding
Surgeon William Jarnagin
Experimental Blood Test Uses EVP Proteins to Detect Cancer

Researchers report a new method that may enable detection of a number of different types of cancer in the early stages.
(Left to right) Medical oncologist Mark Robson, gynecologist Noah Kauff, medical oncologist Zsofia Stadler, and Clinical Genetics Service Chief Kenneth Offit are applying genetic insights to improve the care of cancer patients.
Genetic Information Becomes a Vital Part of Clinical Practice

At Memorial Sloan Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients.
Science Byte
Cancer biologist and pediatric oncologist Alex Kentsis
Blocking Enzymes That Signal DNA Damage Could Be a Treatment Strategy for Childhood Cancers

A new strategy for treating pediatric cancers involves preventing cells from repairing their own DNA.
Announcement
MSK and Hartford leadership holding certificate
MSK Cancer Alliance Grants Hartford HealthCare Cancer Institute Certified Member Status

The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute.
Feature
Albert Kuchler discussing his treatment results with MSK oncologist Bob Li at a recent clinic visit.
For People with a Rare Mouth Cancer, a Targeted Drug Can Be Lifesaving

The drug targets a protein called HER2 found on some salivary gland tumors.
Event
Survivors and family members at our Manhattan event signed their names on a wall and wrote messages to staff and other patients.
Olympic Gold Medalist and Cancer Survivor Shannon Miller Addresses Memorial Sloan Kettering Celebration

Olympic gymnast Shannon Miller was diagnosed with germ cell ovarian cancer, a very rare disease, in 2011 and treated at Memorial Sloan Kettering. Learn more about her inspiring story.
Announcement
José Baselga
News from #AACR16: Precision Medicine Progress, Turbocharged CARs, and Turning Up the Heat against Cancer

At the 2016 American Association for Cancer Research (AACR) conference, there were clear signs that cancer treatment is evolving from a slash-and-burn method to a more precisely targeted, intelligent approach.